10-70233338-T-G
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_021129.4(PPA1):c.-11A>C variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.3 in 1,534,116 control chromosomes in the GnomAD database, including 73,794 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.24 ( 5582 hom., cov: 33)
Exomes 𝑓: 0.31 ( 68212 hom. )
Consequence
PPA1
NM_021129.4 5_prime_UTR
NM_021129.4 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.334
Genes affected
PPA1 (HGNC:9226): (inorganic pyrophosphatase 1) The protein encoded by this gene is a member of the inorganic pyrophosphatase (PPase) family. PPases catalyze the hydrolysis of pyrophosphate to inorganic phosphate, which is important for the phosphate metabolism of cells. Studies of a similar protein in bovine suggested a cytoplasmic localization of this enzyme. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant 10-70233338-T-G is Benign according to our data. Variant chr10-70233338-T-G is described in ClinVar as [Benign]. Clinvar id is 403335.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.325 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PPA1 | ENST00000373232.8 | c.-11A>C | 5_prime_UTR_variant | 1/11 | 1 | NM_021129.4 | ENSP00000362329.2 | |||
PPA1 | ENST00000625364.1 | c.-11A>C | 5_prime_UTR_variant | 1/7 | 5 | ENSP00000486162.1 | ||||
PPA1 | ENST00000495346.1 | n.184+390A>C | intron_variant | 3 | ||||||
PPA1 | ENST00000373230.7 | n.-11A>C | upstream_gene_variant | 5 | ENSP00000362327.4 |
Frequencies
GnomAD3 genomes AF: 0.245 AC: 37207AN: 151916Hom.: 5581 Cov.: 33
GnomAD3 genomes
AF:
AC:
37207
AN:
151916
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.258 AC: 33528AN: 129942Hom.: 5026 AF XY: 0.265 AC XY: 18662AN XY: 70340
GnomAD3 exomes
AF:
AC:
33528
AN:
129942
Hom.:
AF XY:
AC XY:
18662
AN XY:
70340
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.307 AC: 423707AN: 1382088Hom.: 68212 Cov.: 35 AF XY: 0.306 AC XY: 208271AN XY: 681672
GnomAD4 exome
AF:
AC:
423707
AN:
1382088
Hom.:
Cov.:
35
AF XY:
AC XY:
208271
AN XY:
681672
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.245 AC: 37204AN: 152028Hom.: 5582 Cov.: 33 AF XY: 0.248 AC XY: 18456AN XY: 74322
GnomAD4 genome
AF:
AC:
37204
AN:
152028
Hom.:
Cov.:
33
AF XY:
AC XY:
18456
AN XY:
74322
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
534
AN:
3474
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 29, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at